MIRA INFORM REPORT

 

 

Report Date :

07.03.2011

 

IDENTIFICATION DETAILS

 

Name :

BAYER  MATERIALSCIENCE  LTD.

 

 

Registered Office :

77/F., The Center, 99 Queen’s Road Central

 

 

Country :

Hong Kong

 

 

Date of Incorporation :

11.02.1998

 

 

Com. Reg. No.:

21927744

 

 

Legal Form :

Private Limited Company

 

 

Line of Business :

Importer and Exporter of all kinds of plastic raw materials.

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 


 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – December 31, 2010

 

Country Name

Previous Rating

                   (30.09.2010)                  

Current Rating

(31.12.2010)

Hong Kong

a2

a2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

company Name and address

 

BAYER  MATERIALSCIENCE  LTD.

 

 

company ADDRESS    

 

77/F., The Center, 99 Queen’s Road Central, Hong Kong.

PHONE:            2895 5888,  2158 2467

FAX:                 3526 4505,  3526 4730

E-MAIL:            dirk.lang@bayermaterialscience.com

 

 

MANAGEMENT

 

Managing Director:  Mr. Wolfgang Werner Miebach

 

 

SUMMARY

 

Incorporated on:             11th February, 1998.

 

Organization:                 Private Limited Company.

 

Capital:                         Nominal:           HK$100,000.00

Issued:              HK$100,000.00

 

Business Category:        Plastic Material Trader.

 

Group Net Sales:-          (Year ended 31-12-2009)

€31,168 million  (Whole Group)

  7,520 million  (Bayer MaterialScience Subgroup)

 

Group Employees:-        (As at 31-12-2009)

108,400.  (Whole Group)

14,300.  (Bayer MaterialScience Subgroup)

 

Employees:                   200.

 

Main Dealing Banker:     Deutsche Bank AG, Hong Kong Branch.

 

Banking Relation:           Good.


company ADDRESS

 

Registered Head Office:-

77/F., The Center, 99 Queen’s Road Central, Hong Kong.

 

Holding Company:-

Bayer Far East Service Co. Ltd., Hong Kong.

 

Intermediate Holding Company:-

Bayer MaterialScience AG, Germany.

 

Ultimate Holding Company:-

Bayer AG, Germany.

 

Affiliated Companies:-

Bayer Group of Companies

1. BCrSV GmbH, Germany.

2. BHCV GmbH, Germany.

Agreva GmbH, Germany.

AgrEvo Middle East (Cyprus) Ltd., Cyprus.

AgrEvo Verwaltungsgesellschaft mbH, Germany.

Ausbildungsinitiative Rheinland GmbH, Germany.

Aventis CropScience Malawi Ltd., Malawi.

Bayer (Beijing) Sheet Co. Ltd., China.

Bayer (China) Ltd., China.

Bayer (Malaysia) Sdn. Bhd., Malaysia.

Bayer (Sichuan) Animal Health Co. Ltd., China.

Bayer (South East Asia) Pte. Ltd., Singapore.

Bayer 04 Leverkusen Sportförderung gGmbH, Germany.

Bayer 04 Marketing GmbH, Germany.

Bayer 04 Mobilien GmbH, Germany.

Bayer Algerie S.P.A., Algeria.

Bayer Australia Ltd., Australia.

Bayer BioScience Pvt. Ltd., India.

Bayer Co. (Malaysia) Sdn. Bhd., Malaysia.

Bayer Coatings Systems Shanghai Co. Ltd., China.

Bayer CropScience (China) Co. Ltd., China.

Bayer CropScience (OHQ) (Malaysia) Sdn. Bhd., Malaysia.

Bayer CropScience (Pvt) Ltd., Pakistan.

Bayer CropScience (Thailand) Co. Ltd., Thailand.

Bayer CropScience Co. Ltd., Taiwan.

Bayer CropScience Holdings Pty. Ltd., Australia.

Bayer CropScience Inc., Philippines.

Bayer CropScience K.K., Japan.

Bayer CropScience Ltd., Bangladesh.

Bayer CropScience Ltd., India.

Bayer CropScience Ltd., South Korea.

Bayer CropScience Pty. Ltd., Australia.

Bayer d.o.o. Sarajevo, Bosnia-Herzegovina.

Bayer Distribuidora de Produtos Quimicos e Farmaceuticos Ltda., Brazil.

Bayer Guangyi Panel Co. Ltd., China.

Bayer Healthcare Co. Ltd., China.

Bayer HealthCare Ltd., Hong Kong.

Bayer Healthcare S.r. l., Italy.

Bayer Holding Ltd., Japan.

Bayer Innovation Ventures GmbH, Germany.

Bayer International Services GmbH, Germany.

Bayer Jinling Polyurethane Co. Ltd., China.

Bayer Korea Ltd., South Korea.

Bayer MaterialScience Ltd., Japan.

Bayer MaterialScience Pty. Ltd., Australia.

Bayer MaterialScience Pvt. Ltd., India.

Bayer MaterialScience Trading (Shanghai) Co. Ltd., China.

Bayer Middle East FZE, UAE.

Bayer New Zealand Ltd., New Zealand.

Bayer OÜ, Estonia.

Bayer Pakistan (Pvt) Ltd., Pakistan.

Bayer Pharmaceuticals Pvt. Ltd., India.

Bayer Philippines Inc., Philippines.

Bayer Polymers (Shanghai) Co. Ltd., China.

Bayer Polyurethanes (Shanghai) Co. Ltd., China.

Bayer Polyurethanes Taiwan Ltd., Taiwan.

Bayer Schering Pharma Moçambique Lda., Mozambique.

Bayer Shanghai Pigments Co. Ltd., China.

Bayer Sheet Korea Ltd., South Korea.

Bayer Sichuan Animal Health Co. Ltd., China.

Bayer Taiwan Co. Ltd., Taiwan.

Bayer Technology & Engineering (Shanghai) Co. Ltd., China.

Bayer Technology Services GmbH, Germany.

Bayer Thai Co. Ltd., Thailand.

Bayer TPU (Shenzhen) Co. Ltd., China.

Bayer UK Ltd., UK.

Bayer Uretech Ltd., Taiwan.

Bayer Verwaltungsgesellschaft für Anlagevermögen mbH, Germany.

Bayer Vietnam Ltd., Vietnam.

Bayer Wuxi Leather Chemical Co. Ltd., China.

Bayer Yakuhin Ltd., Japan.

Bayer Zhongxi Agrochemcial Co. Ltd., China.

Bayer Zhongxi Consumer Care Co. Ltd., China.

Bayer Zimbabwe (Pvt) Ltd., Zimbabwe.

Bayer-Handelsgesellschaft mbH, Germany.

Bayer-Unterstützungskasse GmbH, Germany.

Bayhealth Comercializacao de Produtos Farmaceuticos Unipessoal Lda., Portugal.

Bayhealth S.L., Spain.

BayInvest GmbH, Germany.

BayOne Canada Inc., Canada.

BCS (Pvt) Ltd., Pakistan.

BCS Romania S.r.l., Romania.

Berlex Canada Inc., Canada.

Berlex Especialidades Farmaceuticas Lda., Portugal.

Berlifarma Lda., Portugal.

Berlimed-Especialidades Farmaceuticas Lda., Portugal.

Berlipharm B.V., Netherlands.

Bilag Industries Pvt. Ltd., India.

Centro Estrategico Canada Latinoamerica S.A. de C.V., Mexico.

Centrofarma-Industria e Comercio de Prod. Farmaceuticos Lda., Portugal.

Chemdyes Pakistan (Pvt) Ltd., Pakistan.

CIS (U.K.) Ltd., UK.

Comercial Interamericana S.A., Guatemala.

Currenta Geschäftsführungs-GmbH, Germany.

Delinting & Seed Treating Company, USA.

Ehrfeld Mikrotechnik BTS GmbH, Germany.

Epurex Films Geschäftsführungs-GmbH, Germany.

Farmaco Ltda., Brazil.

Fünfte Bayer VV GmbH, Germany.

Genus Grundstücks- und Vermietungsgesellschaft mbH & Co. KG, Germany.

Guangzhou Bayer MaterialScience Co. Ltd., China.

H & R Cosfra Ltd., China.

HTV Gesellschaft für Hochtemperaturverbrennung mbH, Germany.

Icon Genetics Inc., USA.

Imaxeon Pty. Ltd., Australia.

Intendis K.K., Japan.

Job@ctive GmbH, Germany.

Junta Comercializadora de Productos de Latinoamerica S.A. de C.V., Mexico.

Kosinus Grundstücks-Verwaltungs-Gesellschaft mbH, Germany.

Laboratorio Berlimed S.A., Chile.

Lusal Producao Quimico Farmaceutica Luso-Alema Lda., Portugal.

Lusalfarma-Especialidades Farmaceuticas Lda., Portugal.

Medipharm (Pvt) Ltd., Pakistan.

Medrad Asia Pte. Ltd., Singapore.

Medrad Medical Equipment Trading Company, China.

Myanmar Aventis CropScience Ltd., Myanmar.

Nihon Medrad K.K., Japan.

Nunhems Beijing Seed Co. Ltd., China.

Nunhems India Pvt. Ltd., India.

P.T. Bayer Indonesia, Indonesia.

P.T. Bayer MaterialScience Indonesia, Indonesia.

Quimicas Unidas S.A., Cuba.

Rhein Chemie (Qingdao) Ltd., China.

Schering (Malaysia) Sdn. Bhd., Malaysia.

Schering Industrial Products Holdings, UK.

Schering Peruana S.A., Peru.

Schering Pty. Ltd., Australia.

Schering Romania S.r.l., Romania.

Schering Verwaltungsgesellschaft mbH, Germany.

Sechste Bayer VV GmbH, Germany.

Shanghai Fortune Long March - Trace Medical Science Co. Ltd., China.

SIA Bayer, Latvia.

Sumika Bayer Urethane Co. Ltd., Japan.

The SDI Divestiture Corporation, USA.

U I M Agrochemicals (Aust) Pty. Ltd., Australia.

Viterion TeleHealthcare LLC, USA.

ZAO Rhone-Poulenc AO, Russia.

etc.

 

 

BUSINESS REGISTRATION NUMBER

 

21927744

 

 

COMPANY FILE NUMBER

 

0636023

 

 

MANAGEMENT

 

Managing Director:  Mr. Wolfgang Werner Miebach

 

 

CAPITAL

 

Nominal Share Capital: HK$100,000.00 (Divided into 100,000 shares of HK$1.00 each)

 

Issued Share Capital: HK$100,000.00

 

 

SHAREHOLDER

(As per registry dated 11-02-2010)

 

Name

 

No. of shares

Bayer Far East Service Co. Ltd., Hong Kong.

 

100,000

======

 

 

DIRECTORS

(As per registry dated 23-06-2010)

 

Name

(Nationality)

 

Address

Michael KOENIG

W30, Tomson Golf Villa, 1 Long Dong Da Dao, Pudong, Shanghai 201203, China.

 

Wolfgang Werner MIEBACH

Kinderhausen 8, 51381 Leverkusen, Germany.

 

SECRETARY

(As per registry dated 11-02-2010)

 

Name

Address

LEE Yuk Kwan

Flat 1115, 11/F., Sheung Yat House, Upper Ngau Tau Kok Estate, Kwun Tong, Kowloon, Hong Kong.

 

 

HISTORY

 

The subject was incorporated on 11th February, 1998 as a private limited liability company under the Hong Kong Companies Ordinance.

Originally the subject was registered under the name of King Lion Corporation Ltd., name changed to Sybron Chemicals (Hong Kong) Ltd. on 31st July, 1998; changed to Bayer Polymers Co. Ltd. on 26th September, 2001; and further to the present style on 1st September, 2004.

Apart from these, neither material change nor amendment has been ever traced and noted.

 

 

OPERATIONS

 

Activities:                      Importer and Exporter.

 

Lines:                           All kinds of plastic raw materials.

 

Group Employees:-        (As at 31-12-2009)

108,400.  (Whole Group)

14,300.  (Bayer MaterialScience Subgroup)

 

Employees:                   200.

 

Commodities Imported:   Germany, other European countries, India, etc.

 

Markets:                       Worldwide.

 

Group Net Sales:-

 

Period

Whole Group

Bayer MaterialScience Subgroup

Year ended 31-12-2005

€24,701million

-

Year ended 31-12-2006

€28,956 million

-

Year ended 31-12-2007

€32,385 million

€10,435 million

Year ended 31-12-2008

€32,918 million

  9,738 million

Year ended 31-12-2009

€31,168 million

  7,520 million

 

Terms/Sales:                 L/C or as per contracted.

 

Terms/Buying:               L/C, D/P, etc.

 

MEMBERSHIP

 

The Hong Kong General Chamber of Commerce, Hong Kong.
[Membership No. HKB0043]

 

 

FINANCIAL INFORMATION

 

Nominal Share Capital:               HK$100,000.00 (Divided into 100,000 shares of HK$1.00 each)

 

Issued Share Capital:                 HK$100,000.00

 

Group Net Income:                     €1,597 million  (Year ended 31-12-2005)

€1,683 million  (Year ended 31-12-2006)

€4,711 million  (Year ended 31-12-2007)

€1,719 million  (Year ended 31-12-2008)

€1,359 million  (Year ended 31-12-2009)

 

Profit or Loss:                            Business is profitable.

 

Condition:                                  Keeping in an active and satisfactory manner.

 

Facilities:                                  Making active use of general banking facilities.

 

Payment:                                  Met trade commitments on time.

 

Commercial Morality:                 Good.

 

Banker:                                     Deutsche Bank AG, Hong Kong Branch.

 

Standing:                                  Good.

 

 

GENERAL

 

Bayer MaterialScience Ltd. is a wholly-owned subsidiary of Bayer Far East Service Co. Ltd. [Bayer FE], a Hong Kong-registered firm located at the subject’s operating address.  In turn, Bayer FE is a subsidiary of Bayer MaterialScience AG [Bayer MaterialScience], Germany.  The ultimate holding company of the subject is Bayer AG [Bayer], a world famous Germany-based firm which is the holding company of the Bayer Group.

The subject is trading in the products of the Group.

The Group is principally engaged in supplying plastics, basic and fine chemicals flavours, fragrances and aromatic chemicals, polyurethanes, synthetic rubbers and rubber chemicals, coating and colorants, specialty products, fibres, pharmaceuticals, diagnostics, consumer care, crop protection and animal-health products to the Chinese market and importing finished and semi-finished raw materials and other intermediates and native products from the People’s Republic of China.

Bayer is one of the largest diversified international health care and chemicals groups.  Founded in 1863 and headquartered at Leverkusen, Germany, Bayer today has subsidiaries or agencies in almost every country in the world.

At the end of 2009, the Group employed 108,400 people worldwide while the Bayer MaterialScience Subgroup employed 14,300 persons.

In 2009, Bayer was successful in a difficult environment.  It achieved EBITDA (earnings before interest expense, tax, depreciation and amortisation) before special items of €6.5 billion, the third-highest level in its history, and nearly reached its ambitious target of limiting the decline in earnings against the record year 2008 to about 5%.  Moreover, it improved net cash flow by 49% to a record €5.4 billion.  This enabled it to reduce net financial debt by €4.5 billion – a greater amount than planned – to €9.7 billion.  Group sales fell by 5.3% to €31,168 million (2008: €32,918 million).

 

Bayer is research-based and aims for technology leadership in its core activities.

Bayer (China) Ltd., a wholly-owned holding company, was registered in Beijing in September 1994 and is responsible for Bayer’s investments in China.

Bayer has eleven joint ventures and one wholly-owned enterprise in China: Bayer Healthcare Co. Ltd., Rhein Chemie (Qingdao) Ltd., Bayer Wuxi Leather Chemical Co. Ltd., Bayer Shanghai Pigments Co. Ltd., Bayer Sichuan Animal Health Co. Ltd., H & R Cosfra Ltd., Bayer Guangyi Panel Co. Ltd., Bayer Jinling Polyurethane Co. Ltd., Bayer Zhongxi Agrochemcial Co. Ltd., Bayer Zhongxi Consumer Care Co. Ltd., and Shanghai Fortune Long March - Trace Medical Science Co. Ltd.

Currently, the subject is trading in the following products and offering clients with the following services:-

 

Product/Service

Product/Service Remarks

Pharmaceutical and Medicine

 

Veterinary Medicine

From Germany (Importer)

From Germany (Exporter)

Pharmaceutical Preparation

Include veterinary from Germany (Importer)

Include veterinary from Germany (Exporter)

Chemicals (including Plastic Materials)

 

Plastic Materials (including Resins and Sheet)

Include fluorescent plastic from Western Europe (Importer)

Include fluorescent plastic from Western Europe (Exporter)

Textile Chemicals

 

Dyeing, Tanning and Colouring Materials

Dyestuff from Germany (Importer)

Dyestuff from Germany (Exporter)

Industrial Chemicals

From Germany (Importer)

From Germany (Exporter)

Household Chemicals

 

Insecticide

 

Agro-Chemicals

 

Pesticide For Agricultural Use

 

 

 

The subject carries the following brands:-

 

Brand Name

Brand Product/Service

Brand Remarks

Bayer (Brand Owner)

Pharmaceutical Preparation

 

Veterinary Medicine

 

Agro-Chemicals

 

Pesticide For Agricultural Use

 

Insecticide

Insecticides

Industrial Chemicals

 

Dyeing, Tanning and Colouring Materials

 

Plastic Materials (including Resins and Sheet)

 

Haarmann And Reimer (Official Agent)

Industrial Chemicals

SPICE

 

Bayer MaterialScience is an independent, globally operating company within the Bayer Group.  The name Bayer MaterialScience stands for the materials that the company develops and produces.  It also stands for the know-how and expertise of its employees all over the world.

Bayer MaterialScience operates at 30 locations throughout the world.  Sales of some €7.5 billion were achieved in 2009 (2008: €9.7 billion), decreased by 22.7% as compared with previous year.

Bayer MaterialScience is currently making major investments in the boom region of Asia.  The integrated site in Shanghai is being expanded by Bayer into the Group’s largest and most technically advanced production site in the region.  The total investment planned for this site up until 2012 amounts to €2.1 billion, €0.7 billion of which are scheduled for the period from 2009 until 2012.

Bayer MaterialScience’s famous products are coating raw materials bearing the brandnames of “Bayhydrol®” and “Bayhydur®”.  High-grade “Makrolon®”, “Makrofol®” and “Apec®polycarbonates, together with the “Bayblend®” and “Makroblend®” polycarbonate blends, rank among Bayer MaterialScience’s best-sellers.  These products are indispensable when it comes to the production of automotive components, data carriers such as CDs and DVDs, and a large number of other everyday items.  The key product brands of Polyurethanes are “Desmodur®” and “Desmophen®”.  Resins under the brand names “Desmopan®” and “Texin®” are used in technical films and textile coatings, belts, hoses, cables and profiles, in the automotive sector (interior, exterior, and chassis), in a multitude of applications in sports and leisure (e.g. ski and sport shoes and sport equipment), etc.

The customer industries of importance to MaterialScience experienced a slump in business in 2009 that varied in intensity from one region to another.  In the first quarter, particularly, demand plummeted.  The difficult economic conditions gradually improved as the year went on, mainly as a result of the extensive stimulus programs introduced throughout the world.

The subject is fully supported by Bayer MaterialScience and ultimately by Bayer.

On the whole, in view of the parentage of the subject, consider it good for normal business engagements.

 

COURT CASES:            None per our.

 


FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.44.99

UK Pound

1

Rs.73.24

Euro

1

Rs.62.80

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.